Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
GRO Biosciences
start up
United States
- Boston, MA
- 23/07/2024
- Series B
- $60,300,000
GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.
- Industry Pharmaceutical Manufacturing
- Website https://grobio.com/
- LinkedIn https://www.linkedin.com/company/grobio/
Related People
Dan MandellCo Founder
United States -
Boston, Massachusetts
Expanding the amino acid alphabet to make better medicines. Experienced Chief Executive Officer and scientist with a demonstrated history of technology development. Strong business development professional skilled in Computational Biology, Protein Chemistry, Entrepreneurship, Molecular Biology, and Metabolic Engineering.
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)